Cargando…

Hyponatremia: A role for vasopressin receptor antagonists?

Detalles Bibliográficos
Autor principal:	Ramesh, Gourishankar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066888/ https://www.ncbi.nlm.nih.gov/pubmed/30104828 http://dx.doi.org/10.4103/joacp.JOACP_31_18

Ejemplares similares

Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses
por: Rondon-Berrios, Helbert, et al.
Publicado: (2017)

Hyponatremia Associated with Congestive Heart Failure: Involvement of Vasopressin and Efficacy of Vasopressin Receptor Antagonists
por: Ishikawa, San-e, et al.
Publicado: (2023)

Efficacy and Safety of Vasopressin Receptor Antagonists for Euvolemic or Hypervolemic Hyponatremia: A Meta-Analysis
por: Zhang, Xiangyun, et al.
Publicado: (2016)

Vasopressin and Vasopressin Receptor Antagonists
por: Oh, Yun Kyu
Publicado: (2008)

The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia
por: Kim, Sua, et al.
Publicado: (2021)

Vasopressin: Hyponatremia: case report
Publicado: (2021)

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V(2)-Receptor Antagonist Tolvaptan
por: Gaglio, Paul, et al.
Publicado: (2012)

Vasopressin receptor antagonists and their role in clinical medicine
por: Narayen, Girish, et al.
Publicado: (2012)

Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?
por: De Vecchis, Renato, et al.
Publicado: (2016)

The Role of V2 Receptor Antagonists in the Treatment of Hyponatremia
por: Palmer, Biff F.
Publicado: (2013)

Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition
por: Yang, Qiong, et al.
Publicado: (2017)

Hyponatremia Associated with Heart Failure: Pathological Role of Vasopressin-Dependent Impaired Water Excretion
por: Ishikawa, San-e
Publicado: (2015)

Inappropriate Arginine Vasopressin Levels and Hyponatremia Associated with Cyclic Vomiting Syndrome
por: Breinbjerg, Anders, et al.
Publicado: (2015)

Physiologic role of interleukin-1 receptor antagonist
por: Arend, William P, et al.
Publicado: (2000)

The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review
por: Chojnowski, Karol, et al.
Publicado: (2023)

Vasopressin V(1B) Receptor Antagonists as Potential Antidepressants
por: Chaki, Shigeyuki
Publicado: (2021)

Vasopressin associated hyponatremia in critically ill children: A cross-sectional study
por: Alakeel, Yousif S., et al.
Publicado: (2022)

Vasopressin-induced hyponatremia in an adult normotensive trauma patient: A case report
por: Lathiya, Maulik K, et al.
Publicado: (2023)

Vasopressin in vasodilatory shock: is the heart in danger?
por: Hauser, Balázs, et al.
Publicado: (2008)

Increased complexity of vasopressin's vascular actions
por: Landry, Donald W, et al.
Publicado: (2010)

On sepsis, troponin and vasopressin: the bitter truth
por: Gradwohl-Matis, Ilse, et al.
Publicado: (2013)

Effect of vasopressin-induced chronic hyponatremia on the regulation of the middle cerebral artery of the rat
por: Aleksandrowicz, Marta, et al.
Publicado: (2018)

Management of Severe Hyponatremia: Infusion of Hypertonic Saline and Desmopressin or Infusion of Vasopressin Inhibitors?
por: Tzamaloukas, Antonios H., et al.
Publicado: (2014)

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19
por: HAFEEZ, ZEESHAN, et al.
Publicado: (2021)

Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
por: Cid-Jofré, Valeska, et al.
Publicado: (2021)

Dear vasopressin, where is your place in septic shock?
por: Duenser, Martin W, et al.
Publicado: (2005)

Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009)

Post-Transplant Hypotension in Kidney Recipients—Vasopressin to the Rescue?
por: Bajpai, Divya, et al.
Publicado: (2022)

Skin microcirculation and vasopressin infusion: a laser Doppler study
por: Bernard, Francis, et al.
Publicado: (2006)

Is There Escape from Renal Actions of Vasopressin in Rats with a Hyponatremia for Greater than 48 Hours?
por: Cheema-Dhadli, Surinder, et al.
Publicado: (2010)

Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
por: Bracht, Hendrik, et al.
Publicado: (2007)

Arginine vasopressin versus norepinephrine: will the stronger one win the race?
por: Ertmer, Christian, et al.
Publicado: (2006)

Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?
por: Asfar, Pierre, et al.
Publicado: (2009)

Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?
por: Wenzel, Volker, et al.
Publicado: (2006)

OR06-4 Brain Derived Neurotrophic Factor in the Regulation of Supraoptic Vasopressin Neurons in Development of Hyponatremia
por: Balapattabi, Kirthikaa, et al.
Publicado: (2019)

Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats
por: Zhu, Xiaoran, et al.
Publicado: (2020)

Management Challenges in a Child with Chronic Hyponatremia: Use of V2 Receptor Antagonist
por: Krishnan, Sowmya, et al.
Publicado: (2017)

Oxytocin and arginine vasopressin: a bridge between acupuncture and autism spectrum disorder
por: Zhang, Rong, et al.
Publicado: (2022)

The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington’s Disease
por: Maibach, Hilda T., et al.
Publicado: (2022)

Quality Improvement for the Management of Hyponatremia in Kidney Failure: Scholarship of Integration and Application
por: Komatsu, Yasuhiro
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gimet93usigoa7c4gu70r2pcfb